Christopher A. Powers, PharmD

home / authors / christopher-a-powers-pharmd

Articles

August 26th 2017

Impact of Formulary Restrictions on Medication Use and Costs

Xian Shen, PhD Bruce C. Stuart, PhD Christopher A. Powers, PharmD Sarah E. Tom, PhD, MPH Laurence S. Magder, PhD Eleanor M. Perfetto, PhD, MS

Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.

May 11th 2015

Observation Encounters and Subsequent Nursing Facility Stays

Anita A. Vashi, MD, MPH, MHS Susannah G. Cafardi, MSW, LCSW, MPH Christopher A. Powers, PharmD Joseph S. Ross, MD, MHS William H. Shrank, MD, MSHS

Only 1.2% of community-dwelling Medicare beneficiaries who received hospital-based observation services in 2010 were discharged to an SNF not covered by Medicare.